三鑫医疗(300453.SZ)业绩快报：2025年净利润2.6亿元 同比增长15.43%

Core Viewpoint - Sanxin Medical (300453.SZ) reported a revenue of 1.64 billion yuan for the fiscal year 2025, reflecting a year-on-year growth of 9.31%, and a net profit attributable to shareholders of 260 million yuan, which is a 15.43% increase compared to the previous year [1] Group 1: Financial Performance - The company achieved total operating revenue of 1.64 billion yuan, marking a 9.31% increase from the same period last year [1] - The net profit attributable to shareholders reached 260 million yuan, representing a year-on-year growth of 15.43% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses also showed steady growth, indicating enhanced profitability [1] Group 2: Strategic Initiatives - The company focused on strategic development goals and operational plans, executing work in an orderly manner [1] - It made precise judgments on market demand, continuously promoting product iteration and innovation [1] - The company strengthened its international market layout and expanded market share while implementing cost reduction and efficiency enhancement measures [1] Group 3: Competitive Positioning - The company has enhanced its main business competitiveness, laying a solid foundation for long-term value enhancement [1] - The ongoing efforts in refining operational levels have contributed to the improvement of profitability [1]